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Objective. To measure the accuracy and usability of an the image-processing based pill identifier application that we have 
developed. Methods. The subjects selected were medical residents and nurses. Five nurses and five physicians were randomly 
assigned to use either an the image-processing based pill identifier application (n=10), or the conventional pill identifier appli-
cation (n=10). They were instructed to examine 10 pills using the application assigned to them, and searches that took ＜3 mi-
nutes to find candidate drugs were recognized as successes. Among these successful searches, the accuracy was defined to 
identify the correct names of the drugs and the times needed in the correctly identifications were also measured. After using 
one application the subjects were instructed to use the other one and repeat the same process. Finally, they answered a ques-
tionnaire on the usability of the applications. Results. The average proportion searches completed within 3 minutes was 91% 
for the the image-processing based pill identifier application, slightly, but not significantly, higher than that for the conventional 
pill identifier application (85%). The accuracies of the the image-processing based and conventional pill identifier applications 
were similar, 89% and 83%, respectively. In the usability examination, the the image-processing based pill identifier applica-
tion yielded higher scores for the desirable, usable, findable and useful qualities than the conventional pill identifier 
application. Conclusion. The the image-processing based pill identifier application application has a similar accuracy to the ex-
isting conventional pill identifier application, and its usability was also found to be good. (J Rheum Dis 2019;26:111-117)
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INTRODUCTION
Rheumatic diseases are chronic autoimmune diseases 
that mostly progress slowly, and are treated with various 
types of drugs over a long period of time. Treatment often 
involves so-called combination therapy, in which multi-
ple drugs are taken simultaneously [1]; moreover, many 
elderly patients take additional drugs for concomitant 
diseases, which may lead to issues such as polypharmacy 
[2,3]. According to recent reports, polypharmacy is not 
limited to patients with rheumatic diseases, but has also 
become a problem in the general population. Almost 60% 
of adults in the USA took prescription pills in 2012, up 
from 50% in 2000, and 15% of adults took 5 or more pre-
scription pills in 2012, up from 10% in 2000 [4]. Along 
with the increase in the use of drugs, the importance of 
pill identification associated with patient safety manage-
ment is also increasing. For example, the number of tele-
phone calls to U.S. Poison Control Centers increased by 
about 44% from 2003 to 2007, and the number of calls to 
identify pills is also on the rise [5]. 
The importance of pill identification is even more pro-
nounced for inpatients. For instance, when patients with 
rheumatoid arthritis are hospitalized, no problems will 
arise if they bring with them the prescription slips from 
their previous physicians. Since many kinds of drugs are 
produced by several different pharmaceutical companies, 
even if they contain the same ingredients it is often neces-
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Figure 1. Flow diagram of subjects’ enrollment.
sary to identify the specific pills that patients have been 
taking in order to make decisions about treatment. If it is 
not possible to identify the specific pills they have been 
taking, serious adverse drug reactions can be caused by 
excessive drug doses, and diseases can be aggravated by 
choosing to suspend administration, which may threaten 
the safety of patients. Drugs that are commonly pre-
scribed can be easily identified by professionals, but 
physicians with less experience may find it difficult to 
identify them. For these reasons, there are certain rules 
requiring pills to have different shapes and colors to avoid 
confusion between them, and to promote their safe use 
[6]; also, generic pills are required to differ in shape, col-
or, and size in a manner that differentiates them from the 
original versions [7]. 
To prevent a variety of errors and problems caused by 
unidentifiable pills, identification imprints and registra-
tion of drugs are mandatory in Korea, an area that is han-
dled by the Ministry of Food and Drug Safety, and the 
Korea Pharmaceutical Information Center (KPIC, http:// 
www.pharm.or.kr/). The program used in Korea to search 
and identify drugs is based on KPIC data, and users can 
access the web-based program and extract candidate 
drugs by directly entering the shape, color and form of 
pills and the imprints on them. However, it takes a long 
time to search drugs using this method, and success is 
highly dependent on the experience of the users who en-
ter the information.
As information technology (IT) has advanced, demand 
that patients be empowered to self-manage their treat-
ment using IT in order to achieve better outcomes has 
gradually increased [8]. In the area of rheumatic diseases, 
terms such as e-rheumatology and e-health are emerging, 
and attempts are being made to use IT for various pur-
poses [9]. Worldwide, there are approximately 5 billion 
mobile phone subscribers, and smartphones are constant 
companions for many individuals [10]. The App Store 
and Google Play offer around 100,000 health apps, but 
few have been scientifically evaluated [11]. Mobile health 
apps could facilitate self-management and adherence to 
treatment; in addition, they could increase access to care 
for individuals with limited access, and for those unwill-
ing to seek ordinary health care [12]. Against this back-
ground, this study aimed to develop a technology that 
would identify drugs based on photos of pills taken using 
a smartphone application. In this way, the current process 
in which individuals must enter imprinted letters and se-
lect the color and form of pills could be avoided, which 
would reduce the time required for searching, and im-
prove efficiency. It could give consumers a simple way of 
recognizing mystery pills, help prevent unnecessary med-
ication errors, and reduce waste by identifying pills that 
might otherwise be discarded.
The purposes of this study were to measure the accuracy 
of the image-processing based pill identifier application 
developed here, focusing on drugs for rheumatic dis-
eases, and to examine the usability and utility of the appli-
cation by comparing its results with the results achieved 
through searches using the existing conventional pill 
identifier application.
MATERIALS AND METHODS
Study design and subjects 
1) Study design 
Randomized controlled trials were used to evaluate the 
utility of the image-processing based pill identifier appli-
cation compared to the existing conventional pill identi-
fier application, and the same pills were identified using 
the two applications. 
2) Study subjects 
The study subjects were selected from among medical 
personnel with relatively little experience in identifying 
pills: 10 medical residents and 10 nurses (Figure 1). They 
were randomly assigned to the conventional pill identifier 
application and to the image-processing based pill identi-
fier application. The random assignment was conducted 
using the Excel program. The participants voluntarily 
signed a consent form for participation.
Methods 
1) Applications used to identify pills 
Two applications were used. The conventional pill iden-
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Figure 2. Pill identification by the image-processing based pill identifier application. 1. The main page displays three menu items 
(camera, gallery, history). 2. When the camera screen is on, users choose the tablet or capsule form and shape of the pill they want
to search. 3. The progress of extraction of imprints is displayed in the color bar, and when the bar turns orange (meaning finished),
users click the OK button to see the search results. 4. Candidate drugs are listed on the search result screen. 5. When a drug is se-
lected, detailed information on it is presented on the screen.
tifier application consisted of the free application pro-
vided by KPIC. It offers several services on the main page. 
When users click the button to “search drugs by shape,” 
they can enter the imprint on a pill (English letter, Korean 
alphabet, number), and select the form, shape and color 
of the pill; candidate drugs are then listed on the screen. 
For the present study, an image-processing based pill 
identifier application was developed named “ALBOX”. 
When a camera button on the main page is clicked, users 
can select the form and shape and type of a pill, and take 
a photo of it, and the application automatically searches 
its database for the pill. To perform this process, the im-
age-processing based pill identifier application accesses 
the same database provided by KPIC (Supplementary 
Figure 1). The imprints on the pill are extracted from the 
image, and the search results are listed on the screen. 
When the “OK” button is clicked, candidate drugs are 
listed. A detailed explanation of this process is presented 
in Figure 2.
The conventional pill identifier application opens a wide 
range of search options to ensure better results, which 
subsequently leads to a long entry process in which the 
user must type the information in manually. In compar-
ison, the image-processing based pill identifier applica-
tion, ALBOX, only provides a reduced search option; 
however, it replaces the tricky manual search process 
(i.e., typing pill letter and determining colors) with 
automation. We summarized the comparison between 
two applications in Supplementary Table 1.
2) Drugs used for measuring the accuracy levels of the 
applications and time spent searching
In consultation with two rheumatologists, 10 drugs 
commonly used for rheumatic diseases were selected. 
Tablet and capsule forms were included (as well as soft 
and hard capsules) as follows: 4 disease-modifying anti-
rheumatic drugs (DMARDs) and immunosuppressive 
drugs (Haloxin [hydroxychloroquine sulfate] 200 mg, 
Tacrobel [tacrolimus hydrate] 1 mg, Cellcept [mycophe-
nolate mofetil] 250 mg, Cipol-N [microemulsion cyclo-
sporine] 25 mg); 4 anti-inflammatory analgesic drugs 
(Airtal [aceclofenac], Vimovo [naprexen and esomepra-
zole], Tridol [tramadol hydrochloride] 50 mg, Celebrex 
[celecoxib] 200 mg); and 2 anti-osteoporotic agents 
(Evista [raloxifene HCI] 60 mg, Calcio [calcitriol]), as 
shown in Supplementary Table 2 and Supplementary 
Figure 2. 
3) Measuring the accuracy levels of the applications 
and time spent searching 
Study subjects were instructed to install on their devices 
both the conventional and image-processing based pill 
identifier application, and to search 10 pills that were se-
lected in advance using the assigned application. The 
time required to identify each pill was measured. 
Searches that took over 3 minutes were considered to be 
failures to identify drugs, and the subjects were in-
structed to search another pill. Those that took less than 
3 minutes to be presented with candidate drug identities 
were recognized as successes in recognizing drugs, and 
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Drug 1 100 80 0.45 100 100 0.47 74.2±49.9 70.5±49.3 0.83
Drug 2 80 80 1.00 100 100 1.00 53.9±45.0 41.1±21.9 0.80
Drug 3 90 80 1.00 100 100 1.00 48.9±32.2 61.6±41.9 0.89
Drug 4 70 90 0.58   85.7 100 0.27 66.3±43.2 53.7±47.2 0.36
Drug 5 100 90 1.00 100 100 1.00 29.8±12.1 21.8±12.8 0.08
Drug 6 100 100 -   90 80 1.00 41.5±16.3 27.6±11.1 0.02
Drug 7 90 70 0.58 100 100 0.58 36.7±18.9 64.6±45.5 0.25
Drug 8 90 70 0.58 100 100 0.58 35.7±12.6 40.6±34.3 0.25
Drug 9 100 100 - 100 100 - 25.5±12.8 18.6±7.9 0.06
Drug 10 90 90 1.00 100 100 1.00 46.0±26.9 39.2±21.8 0.67
Values are presented as % or mean±standard deviation. *Recognition rate means the percentage of the searches of the 10 drugs
that were completed by the given application within 3 minutes. †Accuracy rate means the percentage of the searches of the 10 
drugs completed within 3 minutes that correctly identified the drug. ‡The mean time needed to identify each drug whose name
was accurately identified by the given application. 
the proportion of such instances in which the correct drug 
was identified was used to evaluate the accuracy of the 
application. The time spent in the correct identifications 
were also measured. 
4) Evaluating the usability of the pill identifier applications 
Usability refers to the user convenience and efficiency of 
tangible and intangible goods such as products and 
services. An evaluation of usability is a process that meas-
ures and evaluates interrelationships between users and 
products or services from the perspective of the users, 
taking into consideration user environments, and the 
purpose of the process is to provide the optimal environ-
ment for users [13]. Morville has proposed a honeycomb 
model as a tool to identify whether a solution addresses 
all facets of the user experience in a holistic manner. The 
honeycomb model evaluates 7 facets of the user experi-
ence, providing a simple and clear structure for ease of un-
derstanding [14].
In this study, the central facet of the honeycomb model–
valuable–was excluded, and the other 6 facets that were 
suitable for this study were reorganized as follows: use-
ful, usable, desirable, findable, accessible, and credible. 
The questionnaires used were composed of 20 questions, 
and a 5-point scale was used, as shown in Supplementary 
Table 3. The higher the score, the more positive was the 
response. Depending on the average score, responses 
were classified as follows: very positive (≥4); positive (≥3); 
normal (=2.5); negative (≤2); and very negative (≤1). 
After conducting the randomly controlled trial, those 
who used the conventional pill identifier application were 
instructed to use the image-processing based pill identi-
fier application following the same process, and vice 
versa. Those who completed these two processes an-
swered the questionnaires on the usability of the two 
applications. 
Statistical analysis 
The demographic characteristics of users in the two 
groups were compared using Mann-Whitney and chi- 
square tests. The time spent to identify individual drugs 
was compared using the Mann-Whitney test, and the cor-
rect answer rates of the two groups were compared using 
the chi-square test. All statistical analyses were con-
ducted using PASW Statistics version 18 (IBM, Armonk, 
NY, USA). P-values ＜0.05 were regarded as statistically 
significant. 
Ethical approval
This study was conducted with approval from the 
Institutional Review Board (IRB) of Hanyang University 
Hospital (Research No.: HYUH 2017-05-006-002).
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Figure 3. Usability test results for the two applications.
RESULTS
Demographic and clinical characteristics of subjects 
The average age of the 20 subjects was 28.5 years 
(standard deviation=4.0), and 13 were females (65%). 
There were no statistically significant differences in age 
(28.6±4.2 vs. 28.3±2.8) and gender (80% vs. 50%) be-
tween the conventional pill identifier application group 
and the image-processing based pill identifier application 
group (p=0.88).
Measuring the accuracy of the image-processing 
based pill identifier application and the time spent 
searching 
Both applications were satisfactory (over 70%) in terms 
recognizing the 10 drugs. The image-processing based 
pill identifier application had a higher recognition rate 
than the conventional pill identifier application for all 
drugs with the exception of one (Cipol-N [microemulsion 
cyclosporine] 250 mg), but the difference was not statisti-
cally significant. In terms of the accuracy of identification, 
the two applications gave similar results when it came to 
the proportion of correct drug identifications among 
those searches completed within 3 minutes. The accuracy 
of the image-processing based pill identifier application 
for (Cipol-N [microemulsion cyclosporine] 250 mg) was 
relatively low, but the difference between the two applica-
tions was not statistically significant. In terms of search-
ing times, the image-processing based pill identifier ap-
plication took slightly longer to search Drug 6 (Vimovo 
[naprexen and esomeprazole]) (41.5±16.3 vs. 27.6± 
11.1, p=0.02), but in other drugs, the difference between 
the two applications was not statistically significant 
(Table 1).
Usability of the image-processing based pill iden-
tifier application 
The results of the evaluation of the usability of the two 
applications are shown in Figure 3. Overall, the im-
age-processing based pill identifier application gave high-
er scores for the desirable, usable, findable and useful 
qualities than the conventional pill identifier application, 
and in particular, had a very high score (4.2 points) for 
desirable. Both applications had scores of normal for 
credible, the score of the conventional pill identifier appli-
cation being 2.7 points, slightly higher than that of the 
image-processing based pill identifier application. Both 
applications gave positive results (3.0 points) for acces-
sible, and there was no statistically significant difference 
between them (Figure 3).
DISCUSSION
The image-processing based pill identifier application 
developed in this study yielded similar results to the ex-
isting conventional pill identifier application in terms of 
the recognition rate of drugs used for rheumatic diseases, 
and time spent searching drugs. The results of the us-
ability evaluation of the image-processing based pill iden-
tifier application were higher in the desirable, usable and 
findable categories than the existing application, but the 
score for credible was not satisfactory. Each question on 
usability was reviewed in detail, and it was found that er-
rors occurred frequently in the use of the application, and 
that the reasons for such errors were not immediately ex-
plained to users, which seems to be the reason why the 
unsatisfactory score was given for credible.
The recognition and accuracy rates of the image-proc-
essing based pill identifier application were very high 
when letters were clearly printed and recorded on pills. 
The accuracy of the application developed in this study 
was relatively low for Cipol-N (microemulsion cyclo-
sporine) 250 mg, which is attributable to the form of the 
pill. It was difficult to recognize the imprints on the soft 
capsule of Cipol-N (microemulsion cyclosporine) 250 
mg, and this seemed to be responsible for the low recog-
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nition and accuracy rates. In a test conducted on various 
drugs prior to this study, it was found that the recognition 
rate of letters engraved on pills was highly dependent on 
the surrounding environment (light and shadow, back-
ground, etc.), and was thus relatively low. An additional 
study is currently being conducted to address this issue, 
in order to develop a device that can shed light from vari-
ous angles, and thus increase the recognition rate of the 
application.
This study is the first attempt both in Korea and abroad 
to develop an application using an image-processing 
based pill identification technology, and to evaluate the 
usability of the application. Several previously developed 
applications for identification of pills search for a pill 
based on user input information. On the other hand, the 
newly developed image-processing based pill identi-
fication searches for a pill based on information objecti-
fied by taking a photo. A method for objectively recogniz-
ing the shape and color of a drug, which individual users 
can judge differently, can reduce the error by users. In ad-
dition, this image-processing based pill identification is 
more intuitive, in that it is input by taking a photo, while 
conventional pill identifier applications are based on drug 
information entered one by one in order. Attempts have 
been gradually made in the field of rheumatology to cre-
ate improved treatment environments, and to obtain bet-
ter disease outcomes by applying IT and electronic de-
vices [8,15]. The image-processing based pill identifier 
application developed in this study is expected to improve 
medical service environments, and to provide a positive 
example of the empowerment of patients.
Meanwhile, the image-processing based pill identifier 
application has some limitations, such as low recognition 
rates for some forms of pills, but by using it, medical per-
sonnel can search drugs that patients have taken in a 
quick and convenient manner by exploiting the accuracy 
and convenience of the application. In addition, it should 
be noted that the results we obtained from the well-con-
trolled environment for clinical studies may not fully re-
flect the results of use in a general environment. Another 
limitation of this study was that only drugs commonly 
employed to treat rheumatic diseases were used to eval-
uate the recognition and accuracy rates of the application. 
We tried to select a range of forms, colors and shapes, but 
it will be important to test a broader range of drugs. 
However, a more careful approach and evaluation should 
be conducted, particularly when using look-alike drugs.
The results of this study suggest that the new applica-
tion will address some of the difficulties and limitations 
of the medical environment. For example, in the existing 
procedures, the drugs that inpatients bring with them are 
delivered to the pharmacy department and have to be per-
sonally identified by professional pharmacists using web-
site searches. The new application can be employed by 
nurses and physicians in wards, as it is not highly depend-
ent on the work experience of individual users. With this 
application, the time required to recognize drugs can be 
shortened, drugs can be identified regardless of location 
and device using smartphones, and information on the 
searched drugs can be easily obtained. Nevertheless, it 
will be important to improve the accuracy of identi-
fication, and to connect the application with the database 
provided by the KPIC for continuous use.
From a long-term perspective, it will be desirable to im-
prove and strengthen the credibility (suggesting reasons 
for errors and countermeasures) and accessibility 
(improving the help service), which were found to be 
weak in the usability evaluation of the application. It will 
also be good to extend the service to the general public, 
not just medical personnel. To do so, the accuracy of drug 
identification needs to be improved, and safeguards need 
to be implemented to prevent inaccurate identification 
results. In particular, artificial intelligence (AI) can be 
used to improve accuracy. In addition, for patients, it will 
be helpful to add the ability to keep records of the medi-
cation prescribed to them, and to see whether this im-
proves drug adherence. The application can be used not 
only to identify drugs for rheumatic diseases; it can also 
be extended to manage chronic diseases for which a num-
ber of drugs have to be administered continuously, and in-
fectious diseases whose outcomes are highly dependent 
on drug adherence.
CONCLUSION
In conclusion, an image-processing based pill identifier 
application has been developed that can be used on 
smartphones. The developed application had a similar 
level of accuracy to the existing conventional pill identi-
fier application when used by medical personnel, and its 
usability was also found to be good. In the future, it will 
be important to extend the usability of the application to 
the general population, and to update the database to in-
crease its accuracy.
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Supplementary Table 1. The comparison between the conventional pill identifier and image-processing based pill identifier 
application
　Characteristics of pill Conventional pill 
identifier application
Image-processing based pill 
identifier application
Color of pill Manual Automated
Letter on the surface of pill Manual Automated
Shape of pill Manual Manual
Type of pill Manual Manual
Special character on the surface of pill Manual N/A
Manufacturer Manual N/A
N/A: not available.
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Supplementary Table 2. Ten drugs of different types selected for the test 
Drug class Brand name of drug Generic name of drug
Disease modifying anti-rheumatic/
immunosuppressive drugs
Haloxin 200 mg Hydroxychloroquine sulfate
Tacrobel 1 mg Tacrolimus hydrate
Cellcept 250 mg Mycophenolate mofetil
Cipol-N 25 mg Microemulsion cyclosporine
Anti-inflammatory analgesic drugs Airtal Aceclofenac
Vimovo Naprexen and esomeprazole
Tridol 50 mg Tramadol hydrochloride
Celebrex 200 mg Celecoxib
Anti-osteoporotic agents Evista 60 mg Raloxifene HCI
Calcio Calcitriol
Usability of Image-based Pill Identification Application
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Supplementary Table 3. Questionnaire for evaluating usability based on the classification system of the honeycomb model 
Evaluation qualities Evaluation content 1 2 3 4 5
Useful Is the pill identification application useful? 
Was the time spent to search drugs shortened? 
Is the information on the dosage and adverse reactions of the 
searched drugs useful? 
Usable Is the overall screen layout of the application easy to view?
Do you think the text and arrangement presented in the application are 
suitable? 
Is the layout of the application intuitively constructed?
Is the overall process of searching drugs streamlined? 
Desirable Was the need to identify drugs addressed?
Does the application provide a different experience to the other 
service? 
Is the application convenient for searching and identifying drugs? 
Is the information on the dosage and adverse reactions of the 
searched drugs useful?
Findable Was the time spent on searching drugs shortened?
Is it easy to find your search records? 
Did the application suggest not too many search results? 
Accessible Is the application helpful? 
Were you able to find the menu you wanted to use easily? 
Did the application provide any way to address problems or 
inconveniences that occurred in the process of searching drugs? 
Credible Did any errors occur while using the application? 
If so, did the application provide clear explanations for such errors?
Were you able to save search results properly? 
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Supplementary Figure 1. System working module of image-processing based pill identifier application. OCR: optical char-
acter recognition, API: application programming interface.
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Supplementary Figure 2. The ten drugs of different types se-
lected for the test (ready for the test).
